Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrea Rubboli

Showing results (51-60 of 201) with videos related to

Pageof 21
Sort By:
World Journal of Cardiology|November 30, 2011
Incidence, clinical impact and risk of bleeding during oral anticoagulation therapyAndrea Rubboli, Cecilia Becattini, Freek Wa Verheugt
American Heart Journal|April 23, 2005
Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulationAndrea Rubboli, Mauro Colletta, Giuseppe Di Pasquale
Giornale Italiano Di Cardiologia (2006)|June 12, 2019
[Optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting: the real question nowadays is...]Andrea Rubboli, Giulia Ricci Lucchi, Sabine Vecchio
Vascular Health and Risk Management|December 15, 2007
Utilizing enoxaparin in the management of STEMIAndrea Rubboli, Alessandro Capecchi, Giuseppe Di Pasquale
Expert Opinion on Pharmacotherapy|August 9, 2017
Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillationWalter Ageno, Jan Beyer-Westendorf, Andrea Rubboli
European Heart Journal|February 23, 2023
The European Society of Cardiology Working Group on ThrombosisAndrea Rubboli, Diana A Gorog, Gemma Vilahur
Giornale Italiano Di Cardiologia (2006)|May 26, 2021
[Concepts and preconceptions on the use of direct oral anticoagulants in Italy: a Delphi consensus panel of the Atherosclerosis Thrombosis, Vascular Biology Study Group (ATBV)]Andrea Rubboli, Walter Ageno, Vittorio Pengo, et al.
Internal and Emergency Medicine|October 19, 2013
Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?Andrea Rubboli, Jonas Oldgren, Francisco Marìn, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 24, 2015
Management and outcome of major bleeding in patients on triple therapy after coronary stenting. Clues from the WARfarin and coronary STENTing (WAR-STENT) registryAndrea Rubboli, Paolo Calabrò, Francesco Saia, et al.
Indian Heart Journal|May 7, 2022
In-hospital antithrombotic therapy and outcomes of elderly patients on warfarin undergoing percutaneous coronary intervention: Insights from the WAR-STENT registrySilvia Zagnoni, Gianluca Campo, Alessandro Sciahbasi, et al.
Pageof 21

Showing results (51-60 of 201) with videos related to

Sort By:
Pageof 21
World Journal of Cardiology|November 30, 2011
Incidence, clinical impact and risk of bleeding during oral anticoagulation therapyAndrea Rubboli, Cecilia Becattini, Freek Wa Verheugt
American Heart Journal|April 23, 2005
Regarding antithrombotic treatment after coronary stenting in patients on chronic oral anticoagulationAndrea Rubboli, Mauro Colletta, Giuseppe Di Pasquale
Giornale Italiano Di Cardiologia (2006)|June 12, 2019
[Optimal antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary intervention with stenting: the real question nowadays is...]Andrea Rubboli, Giulia Ricci Lucchi, Sabine Vecchio
Vascular Health and Risk Management|December 15, 2007
Utilizing enoxaparin in the management of STEMIAndrea Rubboli, Alessandro Capecchi, Giuseppe Di Pasquale
Expert Opinion on Pharmacotherapy|August 9, 2017
Once- versus twice-daily direct oral anticoagulants in non-valvular atrial fibrillationWalter Ageno, Jan Beyer-Westendorf, Andrea Rubboli
European Heart Journal|February 23, 2023
The European Society of Cardiology Working Group on ThrombosisAndrea Rubboli, Diana A Gorog, Gemma Vilahur
Giornale Italiano Di Cardiologia (2006)|May 26, 2021
[Concepts and preconceptions on the use of direct oral anticoagulants in Italy: a Delphi consensus panel of the Atherosclerosis Thrombosis, Vascular Biology Study Group (ATBV)]Andrea Rubboli, Walter Ageno, Vittorio Pengo, et al.
Internal and Emergency Medicine|October 19, 2013
Combination of a new oral anticoagulant, aspirin and clopidogrel after acute coronary syndrome: new therapeutic standard?Andrea Rubboli, Jonas Oldgren, Francisco Marìn, et al.
Journal of Cardiovascular Medicine (Hagerstown, Md.)|May 24, 2015
Management and outcome of major bleeding in patients on triple therapy after coronary stenting. Clues from the WARfarin and coronary STENTing (WAR-STENT) registryAndrea Rubboli, Paolo Calabrò, Francesco Saia, et al.
Indian Heart Journal|May 7, 2022
In-hospital antithrombotic therapy and outcomes of elderly patients on warfarin undergoing percutaneous coronary intervention: Insights from the WAR-STENT registrySilvia Zagnoni, Gianluca Campo, Alessandro Sciahbasi, et al.
Pageof 21